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Abstract
Background: The beneficial actions of exercise training on lipid, glucose and energy metabolism and insulin sensitivity 
appear to be in part mediated by PGC-1α. Previous studies have shown that spontaneously exercised rats show at rest 
enhanced responsiveness to exogenous insulin, lower plasma insulin levels and increased skeletal muscle insulin 
sensitivity. This study was initiated to examine the functional interaction between exercise-induced modulation of 
skeletal muscle and liver PGC-1α protein expression, whole body insulin sensitivity, and circulating FFA levels as a 
measure of whole body fatty acid (lipid) metabolism.
Methods: Two groups of male Wistar rats (2 Mo of age, 188.82 ± 2.77 g BW) were used in this study. One group 
consisted of control rats placed in standard laboratory cages. Exercising rats were housed individually in cages 
equipped with running wheels and allowed to run at their own pace for 5 weeks. At the end of exercise training, insulin 
sensitivity was evaluated by comparing steady-state plasma glucose (SSPG) concentrations at constant plasma insulin 
levels attained during the continuous infusion of glucose and insulin to each experimental group. Subsequently, soleus 
and plantaris muscle and liver samples were collected and quantified for PGC-1α protein expression by Western 
blotting. Collected blood samples were analyzed for glucose, insulin and FFA concentrations.
Results: Rats housed in the exercise wheel cages demonstrated almost linear increases in running activity with 
advancing time reaching to maximum value around 4 weeks. On an average, the rats ran a mean (Mean ± SE) of 4.102 
± 0.747 km/day and consumed significantly more food as compared to sedentary controls (P < 0.001) in order to meet 
their increased caloric requirement. Mean plasma insulin (P < 0.001) and FFA (P < 0.006) concentrations were lower in 
the exercise-trained rats as compared to sedentary controls. Mean steady state plasma insulin (SSPI) and glucose 
(SSPG) concentrations were not significantly different in sedentary control rats as compared to exercise-trained 
animals. Plantaris PGC-1α protein expression increased significantly from a 1.11 ± 0.12 in the sedentary rats to 1.74 ± 
0.09 in exercising rats (P < 0.001). However, exercise had no effect on PGC-1α protein content in either soleus muscle or 
liver tissue. These results indicate that exercise training selectively up regulates the PGC-1α protein expression in high-
oxidative fast skeletal muscle type such as plantaris muscle.
Conclusion: These data suggest that PGC-1α most likely plays a restricted role in exercise-mediated improvements in 
insulin resistance (sensitivity) and lowering of circulating FFA levels.
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Background
Insulin resistance, which reflects an impaired response of
glucose transport to insulin, is an early characteristic in
the development of type 2 diabetes [1,2]. Together with
hyperinsulinemia, insulin resistance contributes to devel-
opment of a cluster of interdependent metabolic abnor-
malities [3-6] that in aggregate increase the risk of
cardiovascular disease by about 2-fold and raise the risk
for type 2 diabetes by approximately 5-fold [5]. These
metabolic abnormalities have been referred to by a vari-
ety of names in the past [4], but are now commonly called
'metabolic syndrome' [4-6]. The dramatic increase in the
prevalence of obesity that reflects overnutrition, global
adaptation of the Western type of diet along with
increased consumption of refined sugars (fructose), and
sedentary lifestyles, has led to a marked increase in meta-
bolic syndrome and type 2 diabetes [4,7-12]. Insulin resis-
tance is now considered a direct consequence of obesity-
associated exposure of tissues to elevated dietary nutri-
ents, resulting in accumulation of toxic metabolic by-
products including lipid metabolites in insulin-sensitive
tissues, such as the liver, skeletal muscle, and fat that
become insulin resistant [13-17]. Extensive evidence now
also points to a strong association between hepatic and
skeletal muscle insulin resistance and dysregulation of
whole body glucose homeostasis and fasting hyperglyce-
mia in type-2 diabetes [13-15,17]. The insulin sensitizing
drugs such as thiazolidinediones and metformin that spe-
cifically target insulin resistance are currently in use to
treat type-2 diabetes, but other treatment regimens,
namely dietary modifications and exercise, are also
strongly advocated globally to alleviate the symptoms of
type-2 diabetes. Indeed use of aerobic exercise regimen
as an adjuvant therapy results in significant improvement
in both insulin resistance and insulin action in major
insulin-sensitive tissues [16,18-20]. While a number of
molecular/biochemical mechanisms have been put for-
ward to account for the exercise-induced attenuation of
hepatic/skeletal muscle insulin resistance and enhanced
insulin sensitivity, the underlying mechanism is still not
well defined.
Peroxisome proliferator-activated receptor (PPAR)-γ
coactivator (PGC)-1α is a highly inducible transcriptional
coactivator that controls the transcription of genes
involved in a wide variety of biological programs includ-
ing adaptive thermogenesis, glucose and fatty acid metab-
olism, oxidative phosphorylation, mitochondrial
biogenesis, fiber type switching in skeletal muscle and
heart development [21-24]. Under normal and fed condi-
tions, PGC-1α expression is relatively low in liver as com-
pared to tissues such as heart, skeletal muscle, and brown
adipose that rely on aerobic metabolism for ATP produc-
tion [21,22,25]. Its expression in the liver is robustly
induced in response to acute food deprivation, insulin
resistance or diabetes [25-28], but reduced in obesity
[29]. Both loss-of-function and gain-of-function studies
have shown that PGC-1α differentially impacts the lipid/
glucose metabolism and insulin sensitivity in liver and
skeletal muscle. For example PGC-1α overexpression
results in hepatic insulin resistance, manifested by higher
glucose production and diminished insulin suppression
of gluconeogenesis [30]. In contrast, PGC-1α overexpres-
sion leads to improved muscle insulin sensitivity, mito-
chondrial function and insulin regulated glucose
metabolism [30-32]. PGC-1α deficiency on the other
hand, is accompanied by alterations in energy metabo-
lism in multiple tissues, muscle dysfunstion, hepatic lipid
metabolism and insulin signaling and diminished hepatic
gluconeogenesis [32-35]. When considered together,
these various findings indicate that PGC-1α plays a cen-
tral role in the regulation of metabolic pathways that con-
trol hepatic and skeletal muscle energy metabolism, lipid
and glucose homeostasis and insulin action.
Recent studies have shown that exercise increases the
expression of PGC-1α in skeletal muscle and it has been
suggested that exercise-induced improvements in skeletal
muscle oxidative metabolism and insulin sensitivity
results, at least in part, through the activation and upreg-
ulation of PGC-1α [36-40]. However, it is not clear
whether exercise-induced improvements in insulin regu-
lated hepatic lipid and glucose metabolism is also linked
to the modulation of PGC-1α expression in the liver. Fur-
thermore, it is not clear whether or not activation and
upregulation of PGC-1α occurs uniformly in all skeletal
muscle types or restricted to certain fiber types. To
address these questions, we have utilized a Wistar rat
model of endurance training. The data presented here
indicate that exercise selectively upregulates the protein
expression of PGC-1α in high-oxidative fast (plantaris)
skeletal muscle type. No changes in the PGC-1α protein
expression, however, were noted in either the liver or a
representative of slow oxidative (soleus) skeletal muscle
type. These latter results raised the possibility that exer-
cise-induced improvements that occur in hepatic lipid
and glucose metabolism and insulin sensitivity are not
fully dependent on the activation and participation of
PGC-1α.
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Methods
Animals
All experimental protocols were approved by the Ethics
Committee for Review of Research Projects, of the Hos-
pital of Clinics of the School of Medicine of the Univer-
sity of Sao Paulo. Male Wistar rats, (188.82 ± 2.77 g; 5 wk
of age) were obtained from USP (Sao Paulo, Brazil) and
kept in an environmentally controlled room (22 ± 1°C)
with a 12-h light (0700-1900) and dark (1900-0700) cycle.
Animals had free access to food (Rat Laboratory Chow,
Nuvilab CR-1) and water. After 1 week of acclimation,
rats were assigned to either a sedentary (n = 13) or exer-
cise group (n = 11). Exercising rats were housed individu-
ally in cages (42 × 38 × 38 cm) equipped with running
wheels, each circumrevolution corresponding to 96 cm,
and allowed to run at their own pace for 5 weeks. The
number of exercise wheel revolutions was recorded con-
tinuously with the aid of a digital counter attached to the
wheel to quantify running distance. A group of rats
housed individually in standard laboratory cages com-
prised a sedentary group. Both sedentary and exercising
rats were weighed twice weekly at 0900.
Fasting levels of serum insulin and metabolites
At the end of the training period, exercise rats were not
allowed to run for 24 h and food was removed from cages
of both sedentary and exercising rats at 0800. Rats were
weighed and then anesthetized at 1200 with an injection
of 50 mg/kg of pentobarbital sodium (Thiopentax - Cris-
tália Chemicals Products and Pharmaceutics Ltd, Sao
Paulo, Brazil). A venous sample was obtained from a cut
at the tip of the tail for measurement of glucose, insulin
and free fatty acid (FFA) concentration as described
below.
Measurement of in vivo insulin action
Insulin sensitivity was evaluated using the insulin sup-
pression test previously described [41,42]. Procedure
started at 1200 after 4 h fast. Briefly, rats were anesthe-
tized by an intraperitoneal injection of 50 mg/kg pento-
barbital, and right internal jugular was exposed and
cannulated for administration of the infusate. Rats
received a continuous infusion of glucose (8 mg/kg) and
insulin (2.5 mU/kg) for 180 minutes. With this technique,
comparable steady state plasma insulin levels are reached
in all animals during the last hour of the study. By mea-
suring the steady state plasma glucose concentration dur-
ing the third hour, it is possible to get a direct assessment
of the ability of a fixed concentration of insulin to stimu-
late glucose uptake in two groups. Steady state plasma
glucose and insulin values were calculated from tail blood
samples taken at 10-minute intervals during the last 60
minutes of the infusion and expressed as glucose and
insulin areas under the curve (AUC).
Tissue collection
At the end of 5 weeks of exercise training, all animals
were subjected to an insulin suppression test. Subse-
quently, animals were euthanized for tissue collection.
The fast-twitch plantaris [43] and slow-twitch soleus [44]
muscle and liver tissues were excised, frozen in liquid
nitrogen and stored frozen at -80°C until analyzed.
Biochemical measurements
Serum glucose, nonesterified free fatty acids (NEFAs),
and insulin levels were quantified using kits from
LABTEST, Diagnostica S.A., Minas Gerais, Brazil, Linco
Research Immunoassay, St. Charles, MO, USA and Boeh-
ringer Mannheim, Ingelham, Germany, respectively. For
some studies, serum levels of NEFAs were also measured
by a kit supplied by Wako Pure Chemical Industries Ltd.,
Osaka, Japan.
Immunoblotting
Tissue samples were homogenized in lysis buffer contain-
ing 100 mM Tris buffer, pH 7.5, 1% SDS, 10 mM EDTA,
100 mM sodium pyrophosphate, 100 mM NaF, 10 mM
sodium vanadate, using a Polytron (Brinkmann Instru-
ments, Westbury, NY, USA). Insoluble material was
removed by centrifugation (10,000 g for 40 min at 4°C).
Protein concentration of tissue lysates was determined by
the Bradford dye method (Bio-Rad Laboratories Inc.,
Hercules, CA, USA). Equal amount of protein (75 μg) was
separated on 10% SDS-PAGE gels. Proteins were trans-
ferred to nitrocellulose membranes (Millipore), blocked
overnight with 5% non-fat dry milk in TBS containing
0.02% Tween-20. The nitrocellulose membranes were
washed with TBS containing 0.1% Tween-20 (TBS-T) and
incubated for 4 h at 22°C with primary anti-PGC-1α anti-
body (polyclonal antibody of rabbit against amino acids
1-300 promoted mapped near the N-terminal portion of
PGC-1 - Santa Cruz Biotechnology, Santa Cruz, CA).
Membranes were washed with TBS-T and incubated with
appropriate secondary antibody (horseradish peroxidase-
conjugated anti-rabbit IgG) for 1 h at room temperature.
Bands were visualized using ECL (Amersahm, Piscat-
away, NJ, USA). Subsequently, visualized protein bands
were scanned, photographed, and analyzed by optical
densitometry with Scion Image for Windows (Scion Cor-
poration, National Institutes of Health, Bethesda, MD,
USA). Gel-loading of samples was detected by re-probing
membrane blots with an anti-β-actin monoclonal anti-
body (1:1000 dilution; Santa Cruz Biotechnology, Santa
Cruz, CA). All data were expressed as an arbitrary unit
per unit of total protein mass.
Statistical analysis
Data are expressed as mean ± SE. Differences between
exercise and sedentary groups were determined by an
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unpaired Student's t-test. P values < 0.05 were considered
significant.
Results
Rats housed in the exercise wheel cages demonstrated
almost linear increases in running activity with advancing
time reaching to maximum value around 4 weeks (Figure
1). On an average, the rats ran a mean (Mean ± SE) of
4.102 ± 0.747 km/day. Rats weighed 188.82 ± 2.77 g
before the start of the exercise regimen. Weight gain over
the 5-week period was similar in control and exercise
groups with a final weight of 375.68 ± 5.30 g in control
(sedentary) as compared with 355.85 ± 9.51 g in the rats
allowed to run spontaneously (Table 1). In contrast, exer-
cising rats consumed significantly more food as com-
pared to sedentary controls (P < 0.001) in order to meet
their increased caloric requirement.
The effects of exercise training on basal plasma glucose,
insulin and FFA concentrations are listed in Table 2.
Mean plasma insulin concentrations were lower in the
exercise-trained rats (P < 0.001) as compared to seden-
tary controls. Likewise, exercise also attenuated the cir-
culating levels of FFA (P < 0.006 vs control). In contrast,
exercise-trained rats were able to maintain glucose levels
equal to that of control rats (Table 2).
Steady state plasma glucose (SSPG) and insulin (SSPI)
concentrations of the two groups are shown in Figures 2
and 3. Mean steady state plasma glucose concentrations
were not significantly different in sedentary control rats
as compared to exercise-trained animals (Figure 2). Simi-
larly, steady state plasma insulin concentrations were also
comparable among the two groups (Figure 3). Since SSPG
levels were not changed in response to exercise, it is clear
that insulin-stimulated glucose uptake in insulin-sensi-
tive normal rats was not further impacted by exercise
training.
The effects of exercise training on the PGC-1α protein
expression in soleus and plantaris skeletal muscles and
liver as measured by Western blotting are shown in Fig-
ures 4, 5, 6. Equal loading of protein was confirmed by
probing the membrane blots with an anti-actin monoclo-
nal antibody (data not shown). Plantaris PGC-1α protein
expression increased significantly from a 1.11 ± 0.12 in
the sedentary rats to 1.74 ± 0.09 in exercising rats (P <
0.001) (Figure 4). However, exercise had no effect on
PGC-1α protein content in either soleus muscle or liver
tissue (Figures 5 and 6). These results indicate that exer-
cise training selectively up regulates the PGC-1α protein
expression in the high-oxidative fast skeletal muscle type
such as plantaris muscle.
Discussion
As eluded above, PGC-1α has now emerged as a master
regulator of several major metabolic pathways, including
adaptive thermogenesis, glucose and fatty acid metabo-
lism, oxidative phosphorylation, mitochondrial biogene-
sis, fiber type switching in skeletal muscle, and heart
development [21-26]. Numerous studies also indicate
that PGC-1α is a key factor involved in the regulation of
insulin sensitivity [30-32,35,40] and adaptive responses to
regular endurance exercise, leading to enhanced oxidative
capacity of the skeletal muscle, and consequently,
increased capacity for both lipid and carbohydrate utili-
zation [36,38,39,45]. However, less is known about the
potential beneficial actions of PGC-1α as a mediator of
exercise-induced improvement in hepatic insulin sensi-
tivity and how exercise impacts PGC-1α expression in the
liver. Thus, the current study was initiated with an overall
goal to assess the relative effects of exercise on the PGC-
1α protein expression in two representatives of slow oxi-
dative (soleus) and high-oxidative fast (plantaris) muscle
types as well as in the liver and its relevance to whole
body insulin sensitivity and circulating insulin and fatty
acid levels. The rationale for the present study was based
on our previous findings that exercise training enhances
insulin sensitivity in rats and that this effect is accompa-
nied by a reduction in circulating insulin concentration
[41,46,47]. This phenomenon has been observed in nor-
mal rats [41,46,47] as well as rats fed diets enriched with
glucose, fructose or sucrose [48]. The results of the cur-
rent experiments not only confirm our previous observa-
tions that exercise training attenuates the plasma levels of
Table 1: Mean body weight and food intake
Group Control Exercise
Body weight (g) 375.68 ± 5.30 355.85 ± 9.51
Food intake (g/day) 27.11 ± 0.58 36.48 ± 1.03
Results are Mean ± SE
Figure 1 Average daily voluntary running distance for rats for 
each week is shown. Values are presented as mean ± SE, n = 13.
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insulin, but also lead to a significant reduction in the cir-
culating levels of free fatty acids. More importantly, in the
present study, we have demonstrated that exercise train-
ing selectively upregulates the PGC-1α expression in
high-oxidative fast plantaris muscle, but have no effect on
its expression in either slow oxidative soleus muscle or
the liver.
It is clear from the data presented that plasma FFA lev-
els were lower in exercise trained chow fed normal rats.
However, we cannot tell if lower FFA levels noted in exer-
cise trained rats were due to increased fatty acid oxida-
tion by liver and/or skeletal muscle or simply the negative
impact of running on the hormone-sensitive lipase (HSL)
and adipose triacylglycerol lipase (ATGL), the two key
enzymes involved in lipid hydrolysis and release of FFA
from adipose tissue depots. The latter possibility is
unlikely given that optimal functioning of both HSL and
ATGL is necessary in maintaining adequate supply of
FFA to sustain whole body substrate metabolism in
response to exercise [49,50]. A more likely possibility that
needs to be considered is that exercise training may lower
protein expression of liver MTP, a molecule that is essen-
tial for VLDL assembly and secretion [51], and in turn
causes increased channeling of FFA for their disposal
through oxidation. Indeed, it has been shown that exer-
cise training reduces VLDL synthesis and/or secretion at
least in high-fat fed rats most likely through modulation
of MTP [52]. Whether or not exercise-induced negative
regulation of MTP-VLDL ultimately turns out to be
responsible for the attenuation of dyslipidemia will
depend on the results of future studies, but the observed
reduction in circulating FFA levels supports the view that
this possibility is worthy of continued consideration.
Exercise is known to cause an acute and transient
increase in skeletal muscle PGC-1α gene expression
[36,37,53,54]. Conversely, cessation of physical activity
reduces the skeletal muscle PGC-1α mRNA expression
[54]. It is suggested that exercise-increased levels of skele-
tal muscle PGC-1α leads to enhanced mitochondrial
electron transport activities that enables cells to meet ris-
ing energy demand. We show here that spontaneous
wheel running up regulates PGC-1α protein expression
only in plantaris muscle, but not in soleus muscle. These
results are in agreement with a previous study showing
that voluntary wheel running of female ICR mice was
associated with a selective increase in PGC-1α protein
expression in plantaris muscle [55]. However, we cannot
tell if the enhanced PGC-1α protein expression in planta-
ris muscle noted in the running rats was due to the effect
of exercise training or simply the reflection of plantaris
muscle hypertrophy [56]. Moreover, it is also unclear
whether steady state increases in PGC-1α expression
results from increased de novo synthesis, decreased deg-
radation or both. Clearly, further studies will be necessary
to investigate these possibilities.
The observation that exercise selectively up regulates
the expression of PGC-1α only in the plantaris muscle
points to a potential dissociation between exercise-medi-
ated modulation of PGC-1α and improvements in skele-
tal muscle oxidative metabolism. Most of the previous
studies have shown a positive correlation between exer-
cise-induced changes in total skeletal PGC-1α mRNA
and mitochondrial electron transport activities
Table 2: Mean basal plasma glucose, free fatty acids (FFA) 
and insulin concentrations
Group Control Exercise
Plasma insulin (ng/dl) 1.45 ± 0.14 0.70 ± 0.12*
Plasma glucose (mg/dl) 122.40 ± 2.62 117.60 ± 3.69
Plasma FFA (mEq/dl) 1.61 ± 0.11 1.12 ± 0.11**
Results are Mean ± SE
*P = 0.001 vs control; **P = 0.006 vs control
Figure 2 Steady state plasma glucose (SSPG) concentrations in 
control sedentary and 5-week exercise-trained rats. Values are 
mean ± SE. n = 12-13 rats/group.
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Figure 3 Steady state plasma insulin (SSPI) concentrations in 
control sedentary and 5-week exercise-trained rats. Values are 
mean ± SE with n = 12-13 rats/group.
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[36,37,53,54,57,58]. Our results raise the possibility that
contrary to the previous findings, PGC-1α may not func-
tion as a global regulator of oxidative metabolism in
response to exercise. Instead, we suggest that exercise-
mediated improvement in skeletal muscle oxidative
metabolism may involve improved PGC-1α action in spe-
cific muscle types (e.g., oxidative muscle such as plantaris
muscle) or exercise-induced recruitment other biologi-
cally active compounds leading to increased functional
efficacy of PGC-1α [59-65]. In addition, exercise-induced
potential alterations in acetylation, phosphorylation, and/
or methylation status of PGC-1α could also positively
impact its function (65). Furthermore, since we have used
5 weeks of voluntary wheel running exercise regimen,
there remains the possibility that we may have missed any
potential transient increases in PGC-1α in soleus muscle
studied here. Indeed, exercise is known to cause an acute
and transient increase in PGC-1α gene expression in var-
ious skeletal muscle types [36,37,53,54,66] The follow-up
studies are underway to assess the impact of short- and
long-term exercise training on the expression of PGC-1α
not only in these two muscle types, but also in a variety of
other skeletal muscle types with differing fiber composi-
tion [67]. Also, experiments are in progress to determine
effects of short-term and long-term exercise treatment
regimen on the acetylation, phosphorylation, and/or
methylation status of PGC-1α in specific skeletal muscle
types as well as in liver.
Previous studies have shown that expression in the liver
is robustly induced in response to acute food deprivation,
insulin resistance or diabetes [25-28], but reduced in obe-
sity [29]. Both loss-of-function and gain-of-function
studies have shown that PGC-1α over expression results
in hepatic insulin resistance, while PGC-1α deficiency is
accompanied by alterations in hepatic energy and lipid
metabolism, lipid accumulation (steatosis), insulin signal-
ing and diminished hepatic gluconeogenesis [33-35].
These observations have led to a general thinking that
hepatic PGC-1α may function as a negative modulator of
insulin sensitivity, and lipid and glucose metabolism.
Despite our expectations that exercise-mediated
improvement in hepatic oxidative metabolism [68-70]
should accompany a significant decline in PGC-1α
expression, we found no change in its expression at the
end of 5-weeks of exercise training of rats. It remains pos-
sible that at some point beyond 5-weeks of training,
PGC-1α expression may be significantly altered or that
exercise may indirectly influence PGC-1α through modu-
lation of SIRT1 which serves as a regulator of PPARα-
PGC-1α directed gene expression in liver [65]. Likewise,
it is possible that we may have missed a transient change
(decrease) in PGC-1α expression during the early phase
of the exercise treatment regimen. Moreover, we tested
the effect of exercise only in male Wistar rats, in which
Figure 4 Total PGC-1α protein content in plantaris muscle as-
sessed by Western blotting in sedentary control and exercised 
rats. Values are mean ± SE with n = 8 rats/group. *P < 0.001 vs seden-
tary control.
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Figure 5 Total PGC-1α protein content in soleus muscle assessed 
by Western blotting in sedentary control and exercised rats. Val-
ues are mean ± SE with n = 8 rats/group.
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Figure 6 Total PGC-1α protein content in liver tissue assessed by 
Western blotting in sedentary control and exercised rats. Values 
are mean ± SE with n = 8 rats/group.
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animals were subjected to voluntary wheel running start-
ing at 5 weeks of age. Thus, our findings do not preclude
the possibility that other important factors such as strain,
sex, and age at the start of the exercise regimen may ren-
der animals more responsive to exercise-induced changes
in PGC-1α expression in the liver.
In conclusion, results of the present study indicate that
5 weeks of voluntary wheel training exercise results in a
significant reduction in circulating levels of insulin and
FFA. Western blot analysis indicated that exercise selec-
tively up regulated the PGC-1α protein expression, a
major mediator of exercise-induced improvements in
skeletal muscle oxidative metabolism and insulin sensi-
tivity, in the high-oxidative plantaris muscle. In contrast,
exercise training had no effect on the PGC-1a expression
in either the slow-oxidative soleus muscle or liver. Based
on these findings, we conclude that PGC-1α plays a
minor role in exercise-mediated improvements in insulin
resistance (sensitivity) and lowering of circulating FFA
levels.
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